Reduced fluoroquinolone Susceptibility in Salmonella enterica isolates from travelers, Finland

Emerging Infectious Diseases

Volumn 15, Issue 5, 2009, Pages 809-812

  Lindgren, Marianne M ^a   Kotilainen, Pirkko ^a,b   Huovinen, Pentti ^a   Hurme, Saija ^c   Lukinmaa, Susanna ^a   Webber, Mark A ^d   Piddock, Laura J V ^d   Siitonen, Anja ^a   Hakanen, Antti J ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG SENSITIVITY; FINLAND; HEALTH SURVEY; HUMAN; MALAYSIA; NONHUMAN; SALMONELLA ENTERICA; THAILAND; TRAVEL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FINLAND; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEROTYPING; TRAVEL;

EID: 66149108777     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1505.080849     Document Type: Article

References (12)

1. Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, Angulo FJ. Increase in nalidixic acid resistance among non-typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob Agents Chemother. 2007;51:195-7. DOI: 10.1128/AAC.00222-06
2. Chau TT, Campbell JI, Galindo CM, Van Minn Hoang N, Diep TS, Nga TT, et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism, of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother. 2007;51:4315-23. DOI: 10.1128/AAC.00294-07
3. Hakanen AJ, Kotilainen P, Pitkänen S, Huikko S, Siitonen A, Huovinen P. Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Antimicrob Chemother. 2006;57:569-72. DOI: 10.1093/jac/dk1002
4. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis. 2001;7:996-1003.
5. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J Clin Microbiol. 1999;37:3572-7.
6. Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol. 2005;43:5775-8. DOI: 10.1128/JCM.43.11.5775-5778.2005
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. Vol.27. Wayne (PA): The Committee; 2007. Document no. M-100-S17.
8. Mølbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, et al. An outbreak of multidrug-resistant, quinoloneresistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med. 1999;341:1420-1425 DOI: 10.1056/NEJM199911043411902
9. Lukinmaa S, Nakari UM, Liimatainen A, Siitonen A. Genomic diversity within phage types of Salmonella enterica ssp. enterica serotypes Enteritidis and Typhimurium. Foodborne Pathog Dis. 2006;3:97-105. DOI: 10.1089/fpd.2006.3.97
10. Cavaco LM, Hendriksen RS, Aarestrup FM. Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated, in Denmark and. Thailand. J Antimicrob Chemother. 2007;60:704-706 DOI: 10.1093/jac/dkm261
11. Hopkins KL, Day M, Threlfall EJ. Plasmid-mediated quino lone resistance in Salmonella enterica, United Kindom. Emerg Infect Dis. 2008;14:340-2. DOI: 10.3201/eid1402.070573
12. Threlfall EJ, Ward LR, Skinner JA, Smiths HR, Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet. 1999;353:1590-1. DOI: 10.1016/80140-6736(99)01001-6